Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Veno-arterial ECMO in sickle cell disease for urgent cardiac surgery.

de Roux Q, Maghrebi S, Fiore A, Arminot-Fremaux M, Dessalle T, Lim P, Folliguet T, Bartolucci P, Langeron O, Mongardon N.

Ann Thorac Surg. 2019 Jul 27. pii: S0003-4975(19)31063-X. doi: 10.1016/j.athoracsur.2019.05.093. [Epub ahead of print]

PMID:
31362014
2.

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Gérardin C, Moktefi A, Couchoud C, Duquesne A, Ouali N, Gataut P, Karras A, Anglicheau D, Lefaucheur C, Figueres L, Albano L, Lionet A, Novion M, Ziliotis MJ, Louis M, Del Bello A, Matignon M, Dahan K, Habibi A, Galacteros F, Bartolucci P, Grimbert P, Audard V.

Br J Haematol. 2019 Jul 26. doi: 10.1111/bjh.16113. [Epub ahead of print]

PMID:
31348518
3.

Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome.

Raffetin A, Melica G, Audureau E, Habibi A, Decousser JW, Fourati S, Razazi K, Lepeule R, Guillaud C, Khellaf M, Bartolucci P, Gallien S.

Med Mal Infect. 2019 May 11. pii: S0399-077X(18)30758-3. doi: 10.1016/j.medmal.2019.04.391. [Epub ahead of print]

PMID:
31088757
4.

Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease.

Messonnier LA, Gellen B, Lacroix R, Peyrot S, Rupp T, Mira J, Peyrard A, Berkenou J, Galactéros F, Bartolucci P, Féasson L.

Med Sci Sports Exerc. 2019 Sep;51(9):1795-1801. doi: 10.1249/MSS.0000000000001993.

PMID:
30920486
5.

Intracranial aneurysms in sickle cell disease: Aneurysms characteristics and modalities of endovascular approach to treat these patients.

Gallas S, Tuilier T, Ebrahiminia V, Bartolucci P, Hodel J, Gaston A.

J Neuroradiol. 2019 Mar 20. pii: S0150-9861(19)30200-7. doi: 10.1016/j.neurad.2019.03.001. [Epub ahead of print] Review.

PMID:
30904450
6.

Characteristics of Moyamoya Syndrome in Sickle-Cell Disease by Magnetic Resonance Angiography: An Adult-Cohort Study.

Kauv P, Gaudré N, Hodel J, Tuilier T, Habibi A, Oppenheim C, Edjlali M, Hervé D, Calvet D, Bartolucci P.

Front Neurol. 2019 Jan 22;10:15. doi: 10.3389/fneur.2019.00015. eCollection 2019.

7.

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Bao EL, Lareau CA, Brugnara C, Fulcher IR, Barau C, Moutereau S, Habibi A, Badaoui B, Berkenou J, Bartolucci P, Galactéros F, Platt OS, Mahaney M, Sankaran VG.

Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.

PMID:
30680775
8.

Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial.

Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P; EXDRE collaborative study group.

Lancet Haematol. 2018 Nov;5(11):e554-e562. doi: 10.1016/S2352-3026(18)30163-7.

PMID:
30389037
9.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.

Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14.

PMID:
30317897
10.

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.

Turpin M, Chantalat-Auger C, Parent F, Driss F, Lionnet F, Habibi A, Maître B, Huertas A, Jaïs X, Weatherald J, Montani D, Sitbon O, Simonneau G, Galactéros F, Humbert M, Bartolucci P, Savale L.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800272. doi: 10.1183/13993003.00272-2018. Print 2018 Oct.

PMID:
30305330
11.

A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Garrett ME, Ashley-Koch A, Telen M, Brugnara C, Galactéros F, Lettre G.

Am J Hematol. 2018 Nov;93(11):E362-E365. doi: 10.1002/ajh.25245. Epub 2018 Sep 9. No abstract available.

PMID:
30105803
12.

Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease.

Calvet D, Tuilier T, Mélé N, Turc G, Habibi A, Abdallah NA, Majhadi L, Hemery F, Edjlali M, Galacteros F, Bartolucci P.

Blood Adv. 2017 Dec 1;1(26):2503-2509. doi: 10.1182/bloodadvances.2017005504. eCollection 2017 Dec 12.

13.

Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

de'Angelis N, Abdalla S, Carra MC, Lizzi V, Martínez-Pérez A, Habibi A, Bartolucci P, Galactéros F, Laurent A, Brunetti F.

Surg Endosc. 2018 May;32(5):2300-2311. doi: 10.1007/s00464-017-5925-y. Epub 2017 Nov 2.

PMID:
29098436
14.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
15.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.

Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.

16.

Determination of hydroxyurea in human plasma by HPLC-UV using derivatization with xanthydrol.

Legrand T, Rakotoson MG, Galactéros F, Bartolucci P, Hulin A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 1;1064:85-91. doi: 10.1016/j.jchromb.2017.09.008. Epub 2017 Sep 7.

PMID:
28915422
17.

A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.

Winchenne A, Cecchini J, Deux JF, De Prost N, Razazi K, Carteaux G, Galacteros F, Habibi A, Bartolucci P, Melica G, Khellaf M, Michel M, Maitre B, Mekontso Dessap A.

Br J Haematol. 2017 Nov;179(4):627-634. doi: 10.1111/bjh.14914. Epub 2017 Sep 14.

PMID:
28905364
18.

Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy.

Audard V, Bartolucci P, Stehlé T.

Clin Kidney J. 2017 Aug;10(4):475-478. doi: 10.1093/ckj/sfx027. Epub 2017 Apr 21.

19.

Thrombolytic therapy for the treatment of acute ischaemic stroke in adults with homozygous sickle cell disease.

Majhadi L, Calvet D, Rosso C, Bartolucci P.

BMJ Case Rep. 2017 Jul 28;2017. pii: bcr-2017-220011. doi: 10.1136/bcr-2017-220011.

20.

Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

Pirenne F, Bartolucci P, Habibi A.

Transfus Clin Biol. 2017 Sep;24(3):227-231. doi: 10.1016/j.tracli.2017.05.016. Epub 2017 Jun 29.

PMID:
28669521
21.

Genome-wide association study of erythrocyte density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Rivera A, Sedzro JC, Beaudoin M, Trudel M, Alper SL, Brugnara C, Galactéros F, Lettre G.

Blood Cells Mol Dis. 2017 Jun;65:60-65. doi: 10.1016/j.bcmd.2017.05.005. Epub 2017 May 13.

PMID:
28552477
22.

Telomere attrition in sickle cell anemia.

Mekontso Dessap A, Cecchini J, Chaar V, Marcos E, Habibi A, Bartolucci P, Ghaleh B, Galacteros F, Adnot S.

Am J Hematol. 2017 Jun;92(6):E112-E114. doi: 10.1002/ajh.24721. Epub 2017 Apr 18. No abstract available.

23.

Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease.

Gaudre N, Cougoul P, Bartolucci P, Dörr G, Bura-Riviere A, Kamar N, Del Bello A.

Am J Transplant. 2017 Aug;17(8):2212-2214. doi: 10.1111/ajt.14263. Epub 2017 Mar 30.

24.

Gene Therapy in a Patient with Sickle Cell Disease.

Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2017 Mar 2;376(9):848-855. doi: 10.1056/NEJMoa1609677.

25.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
26.

Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea.

Stehlé T, Bartolucci P, Bouanane M, Galacteros F, Dudreuilh C, Grimbert P, Deux JF, Audard V.

Am J Hematol. 2016 Dec;91(12):1283-1284. doi: 10.1002/ajh.24544. Epub 2016 Oct 14. No abstract available.

27.

A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.

Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.

Am J Hematol. 2016 Dec;91(12):1181-1184. doi: 10.1002/ajh.24537. Epub 2016 Sep 7.

28.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

29.

Dense red blood cell and oxygen desaturation in sickle-cell disease.

Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FC, Conti M, Rakotoson MG, Habibi A, Khorgami S, Vingert B, Maitre B, Galacteros F, Pirenne F, Bartolucci P.

Am J Hematol. 2016 Oct;91(10):1008-13. doi: 10.1002/ajh.24467. Epub 2016 Aug 4.

30.

Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.

Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.

31.

Pulmonary and cerebral microvasculopathy in a patient with sickle cell disease: A role for dense red blood cells?

Ségot A, Deux JF, Thuillier T, Maitre B, Galactéros F, Bartolucci P.

Am J Hematol. 2016 Sep;91(9):963-4. doi: 10.1002/ajh.24413. Epub 2016 Jul 14. No abstract available.

32.

Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.

Transfusion. 2016 Jul;56(7):1828-33. doi: 10.1111/trf.13611. Epub 2016 May 3.

PMID:
27145018
33.

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V.

Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17.

PMID:
26992059
34.

Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case Report.

Arrestier R, Dudreuilh C, Remy P, Boulahia G, Bentaarit B, Leibler C, Adedjouma A, Kofman T, Matignon M, Sahali D, Dufresne R, Deux JF, Colin C, Grimbert P, Lang P, Bartolucci P, Maitre B, Tran Van Nhieu J, Audard V.

Medicine (Baltimore). 2016 Feb;95(6):e2768. doi: 10.1097/MD.0000000000002768.

35.

Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.

Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A, Galactéros F, Michel M, Frémeaux Bacchi V, Noizat Pirenne F, Bartolucci P.

Blood. 2016 Feb 25;127(8):1062-4. doi: 10.1182/blood-2015-09-669770. Epub 2016 Jan 12. No abstract available.

36.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

37.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.

Eur Heart J. 2016 Apr 7;37(14):1158-1167. doi: 10.1093/eurheartj/ehv555. Epub 2015 Oct 29.

PMID:
26516176
38.

[Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study].

Maazoun F, Gellen Dautremer J, Boutekadjirt A, Pissard S, Habibi A, Bachir D, Rahmouni A, Bartolucci P, Debbache K, Lagrange JL, Michel M, Galacteros F.

Rev Med Interne. 2016 Jan;37(1):5-12. doi: 10.1016/j.revmed.2015.07.005. Epub 2015 Sep 26. French.

PMID:
26410419
39.

First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?

Calvet D, Bernaudin F, Gueguen A, Hosseini H, Habibi A, Galactéros F, Bartolucci P.

Stroke. 2015 Aug;46(8):2315-7. doi: 10.1161/STROKEAHA.115.010153. Epub 2015 Jul 14.

PMID:
26173728
40.

[French guidelines for the management of adult sickle cell disease: 2015 update].

Habibi A, Arlet JB, Stankovic K, Gellen-Dautremer J, Ribeil JA, Bartolucci P, Lionnet F; centre de référence maladies rares « syndromes drépanocytaires majeurs ».

Rev Med Interne. 2015 May 11;36(5 Suppl 1):5S3-84. doi: 10.1016/S0248-8663(15)60002-9. French.

PMID:
26007619
41.

Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.

Rakotoson MG, Di Liberto G, Audureau E, Habibi A, Fauroux C, Khorgami S, Hulin A, Loric S, Noizat-Pirenne F, Galacteros F, Bartolucci P.

Orphanet J Rare Dis. 2015 May 9;10:57. doi: 10.1186/s13023-015-0272-3.

42.

Appendicitis and abscess in an adult patient with intestinal nonrotation: Case report.

Assenza M, Reali C, Valesini L, Marenga G, Bartolucci P, Rossi D, Modini C.

Clin Ter. 2015;166(2):e105-7. doi: 10.7417/CT.2015.1829.

PMID:
25945440
43.

Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.

Vingert B, Tamagne M, Habibi A, Pakdaman S, Ripa J, Elayeb R, Galacteros F, Bierling P, Ansart-Pirenne H, Bartolucci P, Noizat-Pirenne F.

Eur J Immunol. 2015 Jun;45(6):1868-79. doi: 10.1002/eji.201445187. Epub 2015 Apr 15.

44.

The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.

Noizat-Pirenne F, Habibi A, Mekontso-Dessap A, Razazi K, Chadebech P, Mahevas M, Vingert B, Bierling P, Galactéros F, Bartolucci P, Michel M.

Vox Sang. 2015 Apr;108(3):262-7. doi: 10.1111/vox.12217. Epub 2014 Dec 18.

PMID:
25523469
45.

[Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ].

Bartolucci P, de Montalembert M.

Rev Prat. 2014 Oct;64(8):1127-8. French. No abstract available.

PMID:
25510141
46.

[Chronic complications of sickle cell disease].

Bartolucci P, Lionnet F.

Rev Prat. 2014 Oct;64(8):1120-6. French.

PMID:
25510140
47.

[Hemoglobin disorders: an advantage against malaria, but the risk of severe disease].

Bartolucci P.

Rev Prat. 2014 Oct;64(8):1110-1. French. No abstract available.

PMID:
25510137
48.

[Epidemiology of hemoglobin disorders].

Bartolucci P.

Rev Prat. 2014 Oct;64(8):1108-9. French. No abstract available.

PMID:
25510136
49.

First evidence of subclinical renal tubular injury during sickle-cell crisis.

Audard V, Moutereau S, Vandemelebrouck G, Habibi A, Khellaf M, Grimbert P, Levy Y, Loric S, Renaud B, Lang P, Godeau B, Galactéros F, Bartolucci P.

Orphanet J Rare Dis. 2014 Apr 29;9:67. doi: 10.1186/1750-1172-9-67.

50.

Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center.

Gueguen A, Mahevas M, Nzouakou R, Hosseini H, Habibi A, Bachir D, Brugière P, Lionnet F, Ribei JA, Godeau B, Girot R, Ibrahima V, Calvet D, Galactéros F, Bartolucci P.

Am J Hematol. 2014 Mar;89(3):267-72.

Supplemental Content

Loading ...
Support Center